Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Rollema, H., Chambers, L.K., Coe, J.W., Glowa, J., Hurst, R.S., Lebel, L.A., Lu, Y., Mansbach, R.S., Mather, R.J., Rovetti, C.C., Sands, S.B., Schaeffer, E., Schulz, D.W., Tingley, F.D., Williams, K.E.·2007·Neuropharmacology

DOI 10.1016/j.neuropharm.2006.10.016

Cited by (554)

Items 101–200 of 554

Recent developments in 5-HT3 receptor pharmacology
Andrew J. Thompson · 2013 · Trends in Pharmacological Sciences
The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: A review
Cleo Lina Crunelle, Michelle L. Miller, Jan Booij, Wim van den Brink · 2009 · European Neuropsychopharmacology
Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.
Raybuck, Jonathan D., Portugal, George S., Lerman, Caryn, Gould, Thomas J. · 2008 · Behavioral Neuroscience
Substance abuse, memory, and post-traumatic stress disorder
Megan E. Tipps, Jonathan D. Raybuck, K. Matthew Lattal · 2013 · Neurobiology of Learning and Memory
Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensors
Amol V. Shivange, Philip M. Borden, Anand K. Muthusamy, Aaron L. Nichols, Kallol Bera, Huan Bao, Isaac Bishara, Janice Jeon, Matthew J. Mulcahy, Bruce N. Cohen et al. · 2019 · The Journal of General Physiology
Serotonin receptors as potential targets for modulation of nicotine use and dependence
Paul J. Fletcher, A LE, Guy A. Higgins · 2008 · Progress in brain research
Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats
G. Biała, N. Staniak, B. Budzyńska · 2010 · Naunyn-Schmiedeberg's Archives of Pharmacology
Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used
Bernard Le Foll, Munmun Chatterjee‐Chakraborty, Shaul Lev‐Ran, Chanel Barnes, Abhiram P. Pushparaj, Islam Gamaleddin, Yijin Yan, Maram A. T. M. Khaled, Steven R. Goldberg · 2011 · The International Journal of Neuropsychopharmacology
Nicotine reduces established levodopa‐induced dyskinesias in a monkey model of Parkinson's disease
Maryka Quik, Archana Mallela, Jason Ly, Danhui Zhang · 2013 · Movement Disorders
Population pharmacokinetic analysis of varenicline in adult smokers
Patanjali Ravva, Marc R. Gastonguay, Thomas G. Tensfeldt, Hélène M. Faessel · 2009 · British Journal of Clinical Pharmacology
Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals
Joseph P. Schacht, Raymond F. Anton, Patrick K. Randall, Xingbao Li, Scott Henderson, Hugh Myrick · 2014 · Psychopharmacology
Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats
Brandon J. Hall, Corinne Wells, Cheyenne E. Allenby, Mung Yan Lin, Ian Hao, Lindsey Marshall, Jed E. Rose, Edward D. Levin · 2014 · Pharmacology Biochemistry and Behavior
Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of α4β2 nicotinic receptors in rats
Spiller, Krista, Xi, Zheng-Xiong, Li, Xia, Ashby, Charles R., Callahan, Patrick M., Tehim, Ashok, Gardner, Eliot L. · 2009 · Neuropharmacology
Evaluation of chemically diverse 5-HT2C receptor agonists on behaviours motivated by food and nicotine and on side effect profiles
Guy A. Higgins, Leo B. Silenieks, W. Lau, Inés A.M. de Lannoy, D. K. H. Lee, Julia Izhakova, Kathleen M. Coen, Anh Dzung Lê, Paul J. Fletcher · 2012 · Psychopharmacology
Nicotinic receptor-based therapeutics and candidates for smoking cessation
Linda P. Dwoskin, Andrew M. Smith, Thomas E. Wooters, Zhenfa Zhang, Peter Anthony Crooks, Michael Thomas Bardo · 2009 · Biochemical Pharmacology
Recent Developments in Novel Antidepressants Targeting α4β2-Nicotinic Acetylcholine Receptors
Li-Fang Yu, Han-Kun Zhang, Barbara J. Caldarone, Jason Brek Eaton, Ronald J. Lukas, Alan P. Kozikowski · 2014 · Journal of Medicinal Chemistry
Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration
Olivier George, Allison Lloyd, Frank Ivy Carroll, Mohamad Imad Damaj, George F. Koob · 2010 · Psychopharmacology
Recent advances with 5‐HT3 modulators for neuropsychiatric and gastrointestinal disorders
Radomír Jůza, Přemysl Vlček, Eva Mezeiová, Kamil Musílek, Ondřej Soukup, Jan Korábečný · 2020 · Medicinal Research Reviews
Assessing nicotine dependence using an oral nicotine free-choice paradigm in mice
Deniz Bağdaş, Clare M. Diester, Jason Riley, Moriah Carper, Yasmin Alkhlaif, Dana Alomari, Hala Alayoubi, Justin L. Poklis, Mohamad Imad Damaj · 2019 · Neuropharmacology
A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study)
Tsukahara, Hitomi, Noda, Keita, Saku, Keijiro · 2010 · Circulation Journal
α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties
Mineur, Yann S., Einstein, Emily B., Seymour, Patricia A., Coe, Jotham W., O'Neill, Brian T., Rollema, Hans, Picciotto, Marina R. · 2011 · Behavioural Pharmacology
Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes
Gary E. Swan, Harold S. Javitz, Lisa M. Jack, Jennifer Wessel, M Michel, David A. Hinds, R P Stokowksi, Jennifer B. McClure, Sheryl L. Catz, Julie Angerhofer Richards et al. · 2011 · The Pharmacogenomics Journal
Multiple CNS nicotinic receptors mediate l-dopa-induced dyskinesias: Studies with parkinsonian nicotinic receptor knockout mice
Maryka Quik, Carla Campos, Sharon R. Grady · 2013 · Biochemical Pharmacology
Patterns of Nicotinic Receptor Antagonism: Nicotine Discrimination Studies
Emily M. Jutkiewicz, Emily A. Brooks, Adam D. Kynaston, Kenner C. Rice, James Henry Woods · 2011 · Journal of Pharmacology and Experimental Therapeutics
Intersubunit Bridge Formation Governs Agonist Efficacy at Nicotinic Acetylcholine α4β2 Receptors
L.A.H. Rohde, Philip Kiær Ahring, Marianne Lerbech Jensen, Elsebet Østergaard Nielsen, Dan Peters, Charlotte Helgstrand, Christian Krintel, Kasper Harpsøe, Michael Gajhede, J.S. Kastrup et al. · 2011 · Journal of Biological Chemistry
Functional Neurocircuits and Neuroimaging Biomarkers of Tobacco Use Disorder
Matthew T. Sutherland, Elliot A. Stein · 2018 · Trends in Molecular Medicine
Persistent Genital Arousal Disorder: A Case Report in a Woman with Lifelong PGAD Where Serendipitous Administration of Varenicline Tartrate Resulted in Symptomatic Improvement
Joanna Beate Korda, James G. Pfaus, Irwin Goldstein · 2009 · The Journal of Sexual Medicine
Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia
Lynn Wecker, M.E. Engberg, R.M. Philpot, Chase Steven Lambert, C.W. Kang, Jon C. Antilla, Paula C. Bickford, C.E. Hudson, Theresa A. Zesiewicz, Peter P Rowell · 2013 · Neuropharmacology
Cross-Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans
Kenneth A. Perkins, Caryn E. Lerman, Carolyn A. Fonte, Melissa Mercincavage, Maxine L. Stitzer, K. N. Roy Chengappa, A Jain · 2010 · Clinical Pharmacology & Therapeutics
Drug Discrimination in Methamphetamine-Trained Rats: Effects of Cholinergic Nicotinic Compounds
Rajeev I. Desai, Jack Bergman · 2010 · Journal of Pharmacology and Experimental Therapeutics
Emerging pharmacotherapies for alcohol use disorder
Barbara J. Mason · 2017 · Neuropharmacology
Synthesis and Structure−Activity Relationship Studies of 3,6-Diazabicyclo[3.2.0]heptanes as Novel α4β2 Nicotinic Acetylcholine Receptor Selective Agonists
Jianguo Ji, Michael R. Schrimpf, Kevin B. Sippy, William H. Bunnelle, Tao Li, David J. Anderson, Connie R. Faltynek, Carol S. Surowy, Tino Dyhring, Philip Kiær Ahring et al. · 2007 · Journal of Medicinal Chemistry
Varenicline Potentiates Alcohol‐Induced Negative Subjective Responses and Offsets Impaired Eye Movements
Emma Childs, Daniel J. O. Roche, Andrea C. King, Harriet de Wit · 2012 · Alcoholism Clinical and Experimental Research
Mechanisms of Inhibition and Potentiation of α4β2 Nicotinic Acetylcholine Receptors by Members of the Ly6 Protein Family
Meilin Wu, Clare A. Puddifoot, Palmer Taylor, William J. Joiner · 2015 · Journal of Biological Chemistry
The Effects of Extended Pre-Quit Varenicline Treatment on Smoking Behavior and Short-Term Abstinence: A Randomized Clinical Trial
Larry W. Hawk, Rebecca L. Ashare, S F Lohnes, Nicolas J. Schlienz, Jessica D. Rhodes, Stephen T. Tiffany, Julie C. Gass, K. Michael Cummings, Martin Christopher Mahoney · 2011 · Clinical Pharmacology & Therapeutics
Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity α4β2 subunit combination
Anderson, David J., Malysz, John, Grønlien, Jens Halvard, El Kouhen, Rachid, Håkerud, Monika, Wetterstrand, Caroline, Briggs, Clark A., Gopalakrishnan, Murali · 2009 · Biochemical Pharmacology
Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history
Robert W. Gould, Pradeep Garg, Sudha Garg, Michael A. Nader · 2012 · Neuropharmacology
Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines
Victor I. Reus, B. J. Smith · 2008 · International Journal of Clinical Practice
Efficacy and Tolerability of Pharmacotherapies to Aid Smoking Cessation in Adolescents
Steffani R. Bailey, Erin Crew, Emily C. Riske, Seth D. Ammerman, Thomas N. Robinson, Joel D. Killen · 2012 · Pediatric Drugs
The Antinociceptive Effects of Nicotinic Partial Agonists Varenicline and Sazetidine-A in Murine Acute and Tonic Pain Models
Shakir D. AlSharari, F. Ivy Carroll, J. Michael McIntosh, Mohamad Imad Damaj · 2012 · Journal of Pharmacology and Experimental Therapeutics
Nicotinic Acetylcholine Receptor β2 Subunit (CHRNB2) Gene and Short-Term Ability to Quit Smoking in Response to Nicotine Patch
Perkins, Kenneth A., Lerman, Caryn, Mercincavage, Melissa, Fonte, Carolyn A., Briski, Jessica L. · 2009 · Cancer Epidemiology, Biomarkers & Prevention
Mechanism-based medication development for the treatment of nicotine dependence
Zheng‐Xiong Xi, Krista J. Spiller, Eliot L. Gardner · 2009 · Acta Pharmacologica Sinica
Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection
Federica Bono, Veronica Mutti, Chiara Fiorentini, Cristina Missale · 2020 · Biomolecules
Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.
Rebecca L. Ashare, Sherry A. McKee · 2011 · Experimental and Clinical Psychopharmacology
Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation
Darlene H. Brunzell, J. Michael McIntosh, Roger L. Papke · 2014 · Annals of the New York Academy of Sciences
Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal
Rebecca L. Ashare, Heath D. Schmidt · 2014 · Expert Opinion on Drug Discovery
The α5 Neuronal Nicotinic Acetylcholine Receptor Subunit Plays an Important Role in the Sedative Effects of Ethanol But Does Not Modulate Consumption in Mice
Nathan Santos, Susmita Chatterjee, Andrea Henry, Joan Y. Holgate, Selena E. Bartlett · 2012 · Alcoholism Clinical and Experimental Research
Therapeutic advances in the treatment of nicotine addiction: present and future
Giuseppina Casella, Pasquale Caponnetto, Riccardo Polosa · 2010 · Therapeutic Advances in Chronic Disease
Effect of the α4β2∗ nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in β2 knock-out mice with selective re-expression of the β2 subunit in the ventral tegmental area
Christelle Repérant, Stéphanie Pons, Eric Dufour, Hans Rollema, Alain Michel Gardier, Uwe Maskos · 2009 · Neuropharmacology
Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake
Masroor R. Shariff, Maryka Quik, Joan Y. Holgate, Michael Morgan, Omkar L. Patkar, Vincent Tam, Arnauld Belmer, Selena E. Bartlett · 2016 · PLoS ONE
New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice
Deniz Bağdaş, Yasmin Alkhlaif, Asti B. Jackson, Frank Ivy Carroll, Joseph W. Ditre, Mohamad Imad Damaj · 2018 · Neuropharmacology
Treating Tobacco Dependence in Light of the 2008 US Department of Health and Human Services Clinical Practice Guideline
James Taylor Hays, Jon O. Ebbert, Amit Sood · 2009 · Mayo Clinic Proceedings
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes
Allison B. Gold, Caryn E. Lerman · 2012 · Human Genetics
Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers
Shelley L. McColl, AH Burstein, K. R. Reeves, CB Billing, Marilyn J. Stolar, Edward M. Sellers · 2008 · Clinical Pharmacology & Therapeutics
Pharmacotherapy for smoking cessation: present and future
Aubin, Henri-Jean, Karila, Laurent, Reynaud, Michel · 2011 · Current Pharmaceutical Design
Unlocking Nicotinic Selectivity via Direct C‒H Functionalization of (−)-Cytisine
Hugo Rego Campello, Silvia G. del Villar, Aurélien Honraedt, Teresa Minguez, A. Sofia F. Oliveira, Kara E. Ranaghan, Deborah K. Shoemark, Isabel Bermúdez, Cecilia Gotti, Richard Barry Sessions et al. · 2018 · Chem
The current state of tobacco cessation treatment
Humberto Choi, Jorge Ataucuri-Vargas, Charlie Lin, Amanda M. Singrey · 2021 · Cleveland Clinic Journal of Medicine
From antipsychotic to anti-schizophrenia drugs: role of animal models
Mark A. Geyer, Berend Olivier, Marian Joëls, René S. Kahn · 2012 · Trends in Pharmacological Sciences
Dementia praecox redux: A systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia
Arann R. Rowe, Louise Mercer, Valentina Casetti, Kyra-Verena Sendt, Giovanni Giaroli, Sukhwinder Singh Shergill, Derek Kenneth Tracy · 2015 · Journal of Psychopharmacology
The Nicotinic Acetylcholine Receptor Partial Agonist Varenicline Increases the Ataxic and Sedative‐Hypnotic Effects of Acute Ethanol Administration in C57BL/6J Mice
Helen M. Kamens, Jimena Andersen, Marina R. Picciotto · 2010 · Alcoholism Clinical and Experimental Research
Selective α4β2 Nicotinic Acetylcholine Receptor Agonists Target Epigenetic Mechanisms in Cortical GABAergic Neurons
Ekrem Maloku, Bashkim Kadriu, Adrian Zhubi, Erbo Dong, Fabio Pibiri, Rosalba Satta, Alessandro Guidotti · 2011 · Neuropsychopharmacology
Effects of Short-Term Varenicline Administration on Emotional and Cognitive Processing in Healthy, Non-Smoking Adults: A Randomized, Double-Blind, Study
Roel J. T. Mocking, Chris Patrick Pflanz, Abbie Pringle, Elizabeth Parsons, Sarah F. B. McTavish, Philip J. Cowen, Catherine J. Harmer · 2012 · Neuropsychopharmacology
Effects of Varenicline on the Reinforcing and Discriminative Stimulus Effects of Cocaine in Rhesus Monkeys
Robert W. Gould, Paul W. Czoty, Susan H. Nader, Michael A. Nader · 2011 · Journal of Pharmacology and Experimental Therapeutics
Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo
Nimish Sidhpura, Peter H. Redfern, Helen L. Rowley, David J. Heal, Susan Wonnacott · 2007 · Biochemical Pharmacology
Safety and Effectiveness of Varenicline in a Veteran Population with a High Prevalence of Mental Illness
Tara L. Purvis, Scott Mambourg, Tracie M Balvanz, Heather E Magallon, Richard Pham · 2009 · Annals of Pharmacotherapy
Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers
Rebecca L. Ashare, Kathy Z. Tang, A Clementina Mesaros, Ian A. Blair, Frank T. Leone, Andrew A. Strasser · 2012 · Journal of Psychopharmacology
Current Insights into the Mechanisms and Development of Treatments for Heavy-Drinking Cigarette Smokers
Daniel J. O. Roche, Lara A. Ray, Megan M. Yardley, Andrea C. King · 2016 · Current Addiction Reports
Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice
Danielle Gulick, Thomas J. Gould · 2008 · Neurobiology of Learning and Memory
Effects of varenicline on operant self-administration of alcohol and/or nicotine in a rat model of co-abuse
Douglas R. Funk, Stewart S. W. Lo, Kathleen M. Coen, Anh Dzung Lê · 2015 · Behavioural Brain Research
Phase II Crossover Trial of Varenicline in Mild-to-Moderate Alzheimer's Disease
Seong Yoon Kim, Seong Hye Choi, Hans Rollema, Elias M. Schwam, Tom McRae, Sarah Dubrava, Janice Jacobsen · 2013 · Dementia and Geriatric Cognitive Disorders
CC 4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation
Mariaelvina Sala, Daniela Braida, Luca Pucci, Irene Manfredi, Michael J. Marks, Charles R. Wageman, Sharon R. Grady, Barbara Loi, Sergio Fucile, Francesca Fasoli et al. · 2012 · British Journal of Pharmacology
Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats
Ramón Sotomayor‐Zárate, Katia Gysling, Usoa E. Busto, Bruce K. Cassels, Lutske Tampier, Marı́a Elena Quintanilla · 2013 · Psychopharmacology
Varenicline for smoking cessation: A review of the literature
Kirandeep Kaur, Sandeep Kaushal, Sarvesh Chander Chopra · 2009 · Current Therapeutic Research
AT ‐1001: a high‐affinity α3β4 nAChR ligand with novel nicotine‐suppressive pharmacology
Andrea Cippitelli, Jinhua Wu, Kelly A. Gaiolini, Daniela Mercatelli, Jennifer Schoch, Michelle Gorman, Alejandra Ramírez Muñoz, Roberto Ciccocioppo, Taline V. Khroyan, Dennis M. Yasuda et al. · 2014 · British Journal of Pharmacology
Varenicline: New treatment with efficacy in smoking cessation
Victor I. Reus, Ronald Scott Obach, Jotham W. Coe, Hélène M. Faessel, Hans Rollema, Eric J. Watsky, Karen R. Reeves · 2007 · Drugs of today
Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats
Johnson, Joshua E., Slade, Susan, Wells, Corinne, Petro, Ann, Sexton, Hannah, Rezvani, Amir H., Brown, Milton L., Paige, Mikell A., McDowell, Brian E., Xiao, Yingxian et al. · 2012 · Psychopharmacology
Whole tobacco smoke extracts to model tobacco dependence in animals
Katharine Alexandra Brennan, Murray Laugesen, Penelope Truman · 2014 · Neuroscience & Biobehavioral Reviews
Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan
Ataru Igarashi, Hiroki Takuma, Takashi Fukuda, Kiichiro Tsutani · 2009 · PharmacoEconomics
Neuropsychiatric Adverse Events of Varenicline: A Systematic Review of Published Reports
Ahmed, Amir I.A., Ali, Abdullah N.A., Kramers, Cees, Härmark, Linda V.D., Burger, David M., Verhoeven, Willem M.A. · 2013 · Journal of Clinical Psychopharmacology
The effects of varenicline on attention and inhibitory control among treatment-seeking smokers
Jessica D. Rhodes, Larry W. Hawk, Rebecca L. Ashare, Nicolas J. Schlienz, Martin Christopher Mahoney · 2012 · Psychopharmacology
The Role of Mesoaccumbens Dopamine in Nicotine Dependence
David J.K. Balfour · 2015 · Current topics in behavioral neurosciences
Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers
Rebecca L. Ashare, Blake A. Kimmey, Laura E. Rupprecht, Maureen E. Bowers, Matthew R. Hayes, Heath D. Schmidt · 2016 · Translational Psychiatry
Nicotine and ethanol cooperate to enhance ventral tegmental area AMPA receptor function via α6-containing nicotinic receptors
Staci E. Engle, J. Michael McIntosh, Ryan M. Drenan · 2014 · Neuropharmacology
Pharmacotherapies and Personalized Medicine for Alcohol Use Disorder: A Review
Falk W. Lohoff · 2020 · Pharmacogenomics
Effectiveness of Coadministration of Varenicline, Bupropion, and Serotonin Reuptake Inhibitors in a Smoking Cessation Program in the Real-Life Setting
Jaqueline Schölz Issa, Tânia Ogawa Abe, Simone Moura, Paulo Caleb Júnior Lima Santos, Alexandre C. Pereira · 2012 · Nicotine & Tobacco Research
Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats
Magdalena Zaniewska, Andrew C. McCreary, Roman Stefański, Edmund Przegaliński, Małgorzata Filip · 2008 · Synapse
Preclinical Evidence That Activation of Mesolimbic Alpha 6 Subunit Containing Nicotinic Acetylcholine Receptors Supports Nicotine Addiction Phenotype
Darlene H. Brunzell · 2012 · Nicotine & Tobacco Research
Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation
Piotr Tutka · 2008 · Expert Opinion on Investigational Drugs
Varenicline Dose Dependently Enhances Responding for Nonpharmacological Reinforcers and Attenuates the Reinforcement-Enhancing Effects of Nicotine
M. E. Levin, M. T. Weaver, Matthew Ian Palmatier, Anthony R. Caggiula, Alan F. Sved, Eric C. Donny · 2011 · Nicotine & Tobacco Research
Dissociable effect of acute varenicline on tonic versus cue-provoked craving in non-treatment-motivated heavy smokers
Brian L. Hitsman, Lee Hogarth, Li‐Jung Tseng, Jordan C. Teige, William G. Shadel, Dana Britt DiBenedetti, Spencer I. Danto, Theodore C. Lee, Lawrence H. Price, RAYMOND S. NIAURA · 2012 · Drug and Alcohol Dependence
Bupropion–varenicline interactions and nicotine self-administration behavior in rats
Brandon J. Hall, Susan K. Slade, Corinne Wells, Jed E. Rose, Edward D. Levin · 2015 · Pharmacology Biochemistry and Behavior
Evaluation of the cardiovascular effects of varenicline in rats
Engin Burak Selçuk, Meltem Süngü, Hakan Parlakpınar, Necip Ermiş, Elif Taşlıdere, Nigar Vardı, Murat Yalçınsoy, Mustafa Sağır, Alaadin Polat, Mehmet Karataş et al. · 2015 · Drug Design Development and Therapy
Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis
Lawrence K Leung, Francis Patafio, Walter Rosser · 2011 · BMC Clinical Pharmacology
Scaffold Ranking and Positional Scanning Utilized in the Discovery of nAChR-Selective Compounds Suitable for Optimization Studies
Jinhua Wu, Yaohong Zhang, Laura E. Maida, Radleigh G. Santos, Gregory S. Welmaker, Travis M. Lavoi, Adel Nefzi, Yongping Yu, Richard A. Houghten, Lawrence Toll et al. · 2013 · Journal of Medicinal Chemistry
α6-Containing nicotinic acetylcholine receptors in midbrain dopamine neurons are poised to govern dopamine-mediated behaviors and synaptic plasticity
Jennifer N. Berry, Staci E. Engle, J. Michael McIntosh, Ryan M. Drenan · 2015 · Neuroscience
α4β2 * Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders
Roger L. Albin, Martijn L.T.M. Müller, Nicolaas Ida Bohnen, Cathie Spino, Martin F. Sarter, Robert A. Koeppe, Ashley Szpara, Kamin Kim, Cindy Lustig, William T. Dauer · 2021 · Annals of Neurology
The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptors
Luisa Ponzoni, Daniela Braida, Luca Pucci, Andrea Donzelli, Francesca Fasoli, Irene Manfredi, Roger L. Papke, Clare A. Stokes, Giuseppe Cannazza, Francesco Clementi et al. · 2014 · Psychopharmacology
The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats
Neil E. Paterson, Wenzhong Min, Adrian Hackett, David Lowe, Taleen Hanania, Barbara J. Caldarone, Afshin Ghavami · 2010 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal
Turner, Jill R, Wilkinson, Derek S, Poole, Rachel LF, Gould, Thomas J, Carlson, Gregory C, Blendy, Julie A · 2013 · Neuropsychopharmacology
Chemistry and Pharmacology of a Series of Unichiral Analogues of 2-(2-Pyrrolidinyl)-1,4-benzodioxane, Prolinol Phenyl Ether, and Prolinol 3-Pyridyl Ether Designed as α4β2-Nicotinic Acetylcholine Receptor Agonists
Cristiano Bolchi, Ermanno Valoti, Cecilia Gotti, Francesca Fasoli, Paola Ruggeri, Laura Fumagalli, Matteo Binda, Vanessa Mucchietto, Miriam Sciaccaluga, Roberta Budriesi et al. · 2015 · Journal of Medicinal Chemistry